Researchers from Peking University have developed an innovative, noninvasive choroidal angiography technique that enables layer-wise visualization and assessment of choroidal vessels using deep learning. This method, published in Health Data Science, uses an advanced segmentation model capable of processing various qualities of optical coherence tomography (OCT) B-scans, making … [Read more...] about Noninvasive choroidal vessel analysis using deep learning: A novel approach to OCT angiography
News
Effect of the iris-ciliary angle on the prediction of the vault for phakic implantable collamer lens in the manufacturer’s calculator
This study aims to explore the effects of the iris-ciliary angle (ICA) on the accurate prediction of the vault after implantable collamer lens (ICL) using the manufacturer’s online calculation and ordering sys... … [Read more...] about Effect of the iris-ciliary angle on the prediction of the vault for phakic implantable collamer lens in the manufacturer’s calculator
Optogenetic therapy holds promise for treatment of late-stage geographic atrophy
November 10, 2024 4 min watch BARCELONA, Spain — In this Healio Video Perspective from the Euretina congress, Jordi Monés, MD, PhD, discusses an investigational optogenetic therapy for geographic atrophy. Monés said retina specialists have been involved in many revolutions, and optogenetics promises to be the next, thanks to the new … [Read more...] about Optogenetic therapy holds promise for treatment of late-stage geographic atrophy
VIDEO: Dextenza shows promising IOP outcomes in patients with glaucoma
November 09, 2024 2 min watch NEW YORK — In this Healio Video Perspective from OSN New York, Nandini Venkateswaran, MD, of Massachusetts Eye and Ear Infirmary, discusses real-world data investigating the use of Dextenza in patients with glaucoma. Data from more than 10,000 patients was collected using the IRIS registry, with results showing comparable IOP outcomes … [Read more...] about VIDEO: Dextenza shows promising IOP outcomes in patients with glaucoma
This Week in Ophthalmology: Week of November 4, 2024
This transcript is edited for clarity.Hello, I am David Hutton of Ophthalmology Times. Welcome to another edition of this Week in Ophthalmology, looking at the latest news in ophthalmology.This week, I have hand-picked a couple of discussions I had at the American Academy of Ophthalmology meeting last month.First, let’s take a look at my discussion with Dr. Alfredo Saddun, who … [Read more...] about This Week in Ophthalmology: Week of November 4, 2024
FDA extends Prescription Drug User Fee Act date for macular telangiectasia type 2 therapy
November 08, 2024 1 min read Key takeaways: NT-501 is an encapsulated cell therapy for macular telangiectasia type 2. The new Prescription Drug User Fee Act date is March 18, 2025. The FDA has extended its Prescription Drug User Fee Act date for the biologics license application for NT-501, a treatment for macular telangiectasia … [Read more...] about FDA extends Prescription Drug User Fee Act date for macular telangiectasia type 2 therapy
What specific risk factors do you discuss with patients who are prescribed GLP-1 agonists?
November 08, 2024 2 min read Recent research has suggested that GLP-1 agonists used to treat obesity might be associated with a stroke in the optic nerve, but association is not the same as causation. We call a “stroke in the optic nerve” nonarteritic anterior ischemic optic neuropathy (NAION). This is a fancy way of saying lack of blood flow … [Read more...] about What specific risk factors do you discuss with patients who are prescribed GLP-1 agonists?
Specialists discuss concerns over impact of semaglutide on the eye
November 08, 2024 12 min read A paper recently published in JAMA Ophthalmology by Hathaway and colleagues at Harvard suggested a potential association between prescribed semaglutide and an increased risk for nonarteritic anterior ischemic optic neuropathy. Semaglutide is a GLP-1 receptor agonist primarily used as a treatment for diabetes … [Read more...] about Specialists discuss concerns over impact of semaglutide on the eye
Single-pass four-throw pupilloplasty evolves for iris, pupil repair
November 08, 2024 5 min read Traumatic iris repair is not uncommon. Iridodialysis, iris tissue loss and iris prolapse are noted in eye trauma. Lens damage will need phacoemulsification with IOL implantation, and coexisting iris damage should be addressed simultaneously for functional and anatomical outcomes. Recently, single-pass four-throw … [Read more...] about Single-pass four-throw pupilloplasty evolves for iris, pupil repair
Performing cataract surgery at a more physiologic IOP offers benefits
November 08, 2024 4 min read As ophthalmologists, we face almost daily pressure to adopt the latest and greatest technologies and techniques. With so much competing information, it can be challenging to know what new innovations are truly worth pursuing. Trying out the newest gadget or using a new surgical technique is exciting, but the … [Read more...] about Performing cataract surgery at a more physiologic IOP offers benefits